nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—NISCH—Paclitaxel—Docetaxel—stomach cancer	0.0274	1	CbGdCrCtD
Phentolamine—Oral pain—Capecitabine—stomach cancer	0.0178	0.0358	CcSEcCtD
Phentolamine—Injection site reaction—Mitomycin—stomach cancer	0.0159	0.032	CcSEcCtD
Phentolamine—Pain in jaw—Capecitabine—stomach cancer	0.0142	0.0287	CcSEcCtD
Phentolamine—Angina pectoris—Floxuridine—stomach cancer	0.0124	0.025	CcSEcCtD
Phentolamine—Oral pain—Epirubicin—stomach cancer	0.0124	0.0249	CcSEcCtD
Phentolamine—Oral pain—Doxorubicin—stomach cancer	0.0115	0.0231	CcSEcCtD
Phentolamine—Swelling face—Capecitabine—stomach cancer	0.00974	0.0196	CcSEcCtD
Phentolamine—Tenderness—Fluorouracil—stomach cancer	0.00761	0.0153	CcSEcCtD
Phentolamine—Nervous system disorder—Floxuridine—stomach cancer	0.00712	0.0143	CcSEcCtD
Phentolamine—Hypertension—Mitomycin—stomach cancer	0.00602	0.0121	CcSEcCtD
Phentolamine—Gastrointestinal pain—Floxuridine—stomach cancer	0.00593	0.0119	CcSEcCtD
Phentolamine—Abdominal pain—Floxuridine—stomach cancer	0.00574	0.0116	CcSEcCtD
Phentolamine—Injection site pain—Capecitabine—stomach cancer	0.00568	0.0114	CcSEcCtD
Phentolamine—Asthenia—Floxuridine—stomach cancer	0.00521	0.0105	CcSEcCtD
Phentolamine—Diarrhoea—Floxuridine—stomach cancer	0.00496	0.01	CcSEcCtD
Phentolamine—Pain—Mitomycin—stomach cancer	0.00487	0.00981	CcSEcCtD
Phentolamine—Blood pressure increased—Docetaxel—stomach cancer	0.00479	0.00965	CcSEcCtD
Phentolamine—Injection site reaction—Docetaxel—stomach cancer	0.00476	0.00959	CcSEcCtD
Phentolamine—Blood pressure increased—Capecitabine—stomach cancer	0.00464	0.00934	CcSEcCtD
Phentolamine—Vomiting—Floxuridine—stomach cancer	0.00461	0.00929	CcSEcCtD
Phentolamine—Injection site reaction—Capecitabine—stomach cancer	0.00461	0.00929	CcSEcCtD
Phentolamine—Orthostatic hypotension—Irinotecan—stomach cancer	0.0046	0.00925	CcSEcCtD
Phentolamine—Headache—Floxuridine—stomach cancer	0.00455	0.00915	CcSEcCtD
Phentolamine—Nausea—Floxuridine—stomach cancer	0.00431	0.00868	CcSEcCtD
Phentolamine—Angina pectoris—Irinotecan—stomach cancer	0.00424	0.00853	CcSEcCtD
Phentolamine—Asthenia—Mitomycin—stomach cancer	0.00409	0.00823	CcSEcCtD
Phentolamine—Angina pectoris—Fluorouracil—stomach cancer	0.00406	0.00817	CcSEcCtD
Phentolamine—Injection site pain—Epirubicin—stomach cancer	0.00396	0.00797	CcSEcCtD
Phentolamine—Diarrhoea—Mitomycin—stomach cancer	0.0039	0.00785	CcSEcCtD
Phentolamine—Acute coronary syndrome—Irinotecan—stomach cancer	0.00382	0.0077	CcSEcCtD
Phentolamine—Myocardial infarction—Irinotecan—stomach cancer	0.0038	0.00765	CcSEcCtD
Phentolamine—Dizziness—Mitomycin—stomach cancer	0.00377	0.00758	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—stomach cancer	0.00366	0.00738	CcSEcCtD
Phentolamine—Acute coronary syndrome—Fluorouracil—stomach cancer	0.00366	0.00737	CcSEcCtD
Phentolamine—Myocardial infarction—Fluorouracil—stomach cancer	0.00364	0.00733	CcSEcCtD
Phentolamine—Vomiting—Mitomycin—stomach cancer	0.00362	0.00729	CcSEcCtD
Phentolamine—Headache—Mitomycin—stomach cancer	0.00357	0.00718	CcSEcCtD
Phentolamine—Bradycardia—Irinotecan—stomach cancer	0.00354	0.00714	CcSEcCtD
Phentolamine—Nausea—Mitomycin—stomach cancer	0.00338	0.00681	CcSEcCtD
Phentolamine—Flushing—Irinotecan—stomach cancer	0.00323	0.00651	CcSEcCtD
Phentolamine—Cardiac disorder—Irinotecan—stomach cancer	0.00323	0.00651	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—stomach cancer	0.00321	0.00647	CcSEcCtD
Phentolamine—Orthostatic hypotension—Docetaxel—stomach cancer	0.00318	0.0064	CcSEcCtD
Phentolamine—Abdominal pain upper—Docetaxel—stomach cancer	0.00318	0.0064	CcSEcCtD
Phentolamine—Angiopathy—Irinotecan—stomach cancer	0.00316	0.00636	CcSEcCtD
Phentolamine—Mediastinal disorder—Irinotecan—stomach cancer	0.00314	0.00632	CcSEcCtD
Phentolamine—Arrhythmia—Irinotecan—stomach cancer	0.00311	0.00626	CcSEcCtD
Phentolamine—Orthostatic hypotension—Capecitabine—stomach cancer	0.00308	0.00619	CcSEcCtD
Phentolamine—Abdominal pain upper—Capecitabine—stomach cancer	0.00308	0.00619	CcSEcCtD
Phentolamine—Arrhythmia—Fluorouracil—stomach cancer	0.00298	0.006	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—stomach cancer	0.00297	0.00599	CcSEcCtD
Phentolamine—Angina pectoris—Docetaxel—stomach cancer	0.00293	0.0059	CcSEcCtD
Phentolamine—NISCH—smooth muscle tissue—stomach cancer	0.00284	0.0883	CbGeAlD
Phentolamine—Angina pectoris—Capecitabine—stomach cancer	0.00284	0.00571	CcSEcCtD
Phentolamine—Acute coronary syndrome—Docetaxel—stomach cancer	0.00264	0.00532	CcSEcCtD
Phentolamine—Myocardial infarction—Docetaxel—stomach cancer	0.00263	0.00529	CcSEcCtD
Phentolamine—NISCH—pancreas—stomach cancer	0.00263	0.0817	CbGeAlD
Phentolamine—Hypertension—Irinotecan—stomach cancer	0.00262	0.00527	CcSEcCtD
Phentolamine—Acute coronary syndrome—Capecitabine—stomach cancer	0.00256	0.00515	CcSEcCtD
Phentolamine—Myocardial infarction—Capecitabine—stomach cancer	0.00254	0.00512	CcSEcCtD
Phentolamine—Chest pain—Fluorouracil—stomach cancer	0.00247	0.00498	CcSEcCtD
Phentolamine—ADRA1D—epithelium—stomach cancer	0.00246	0.0765	CbGeAlD
Phentolamine—Nervous system disorder—Irinotecan—stomach cancer	0.00243	0.00488	CcSEcCtD
Phentolamine—Bradycardia—Capecitabine—stomach cancer	0.00237	0.00478	CcSEcCtD
Phentolamine—Nervous system disorder—Fluorouracil—stomach cancer	0.00232	0.00468	CcSEcCtD
Phentolamine—Tachycardia—Fluorouracil—stomach cancer	0.00231	0.00466	CcSEcCtD
Phentolamine—Hypotension—Irinotecan—stomach cancer	0.00231	0.00465	CcSEcCtD
Phentolamine—Flushing—Docetaxel—stomach cancer	0.00223	0.0045	CcSEcCtD
Phentolamine—Cardiac disorder—Docetaxel—stomach cancer	0.00223	0.0045	CcSEcCtD
Phentolamine—Paraesthesia—Irinotecan—stomach cancer	0.00222	0.00447	CcSEcCtD
Phentolamine—Hypotension—Fluorouracil—stomach cancer	0.00221	0.00446	CcSEcCtD
Phentolamine—Angiopathy—Docetaxel—stomach cancer	0.00218	0.0044	CcSEcCtD
Phentolamine—Mediastinal disorder—Docetaxel—stomach cancer	0.00217	0.00437	CcSEcCtD
Phentolamine—Cardiac disorder—Capecitabine—stomach cancer	0.00216	0.00435	CcSEcCtD
Phentolamine—Flushing—Capecitabine—stomach cancer	0.00216	0.00435	CcSEcCtD
Phentolamine—Arrhythmia—Docetaxel—stomach cancer	0.00215	0.00433	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—stomach cancer	0.00214	0.00431	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—stomach cancer	0.00214	0.00431	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00213	0.0043	CcSEcCtD
Phentolamine—Paraesthesia—Fluorouracil—stomach cancer	0.00213	0.00428	CcSEcCtD
Phentolamine—Pain—Irinotecan—stomach cancer	0.00211	0.00426	CcSEcCtD
Phentolamine—Angiopathy—Capecitabine—stomach cancer	0.00211	0.00426	CcSEcCtD
Phentolamine—Mediastinal disorder—Capecitabine—stomach cancer	0.0021	0.00423	CcSEcCtD
Phentolamine—Arrhythmia—Capecitabine—stomach cancer	0.00208	0.00419	CcSEcCtD
Phentolamine—NISCH—bone marrow—stomach cancer	0.00207	0.0643	CbGeAlD
Phentolamine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00204	0.00412	CcSEcCtD
Phentolamine—Pain—Fluorouracil—stomach cancer	0.00203	0.00408	CcSEcCtD
Phentolamine—Gastrointestinal pain—Irinotecan—stomach cancer	0.00202	0.00407	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—stomach cancer	0.00198	0.00399	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00198	0.00399	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—stomach cancer	0.00198	0.00398	CcSEcCtD
Phentolamine—Abdominal pain—Irinotecan—stomach cancer	0.00195	0.00394	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—stomach cancer	0.00183	0.00368	CcSEcCtD
Phentolamine—Hypertension—Docetaxel—stomach cancer	0.00181	0.00364	CcSEcCtD
Phentolamine—Chest pain—Docetaxel—stomach cancer	0.00178	0.00359	CcSEcCtD
Phentolamine—Asthenia—Irinotecan—stomach cancer	0.00177	0.00357	CcSEcCtD
Phentolamine—Hypertension—Capecitabine—stomach cancer	0.00175	0.00353	CcSEcCtD
Phentolamine—Chest pain—Capecitabine—stomach cancer	0.00173	0.00348	CcSEcCtD
Phentolamine—Diarrhoea—Irinotecan—stomach cancer	0.00169	0.00341	CcSEcCtD
Phentolamine—Nervous system disorder—Docetaxel—stomach cancer	0.00168	0.00338	CcSEcCtD
Phentolamine—Pruritus—Fluorouracil—stomach cancer	0.00168	0.00337	CcSEcCtD
Phentolamine—NISCH—liver—stomach cancer	0.00167	0.052	CbGeAlD
Phentolamine—Tachycardia—Docetaxel—stomach cancer	0.00167	0.00336	CcSEcCtD
Phentolamine—SIGMAR1—smooth muscle tissue—stomach cancer	0.00165	0.0514	CbGeAlD
Phentolamine—Bradycardia—Epirubicin—stomach cancer	0.00165	0.00333	CcSEcCtD
Phentolamine—Dizziness—Irinotecan—stomach cancer	0.00164	0.00329	CcSEcCtD
Phentolamine—Nervous system disorder—Capecitabine—stomach cancer	0.00162	0.00327	CcSEcCtD
Phentolamine—Diarrhoea—Fluorouracil—stomach cancer	0.00162	0.00326	CcSEcCtD
Phentolamine—Tachycardia—Capecitabine—stomach cancer	0.00162	0.00325	CcSEcCtD
Phentolamine—Cardiac disorder—Methotrexate—stomach cancer	0.00161	0.00324	CcSEcCtD
Phentolamine—Hypotension—Docetaxel—stomach cancer	0.0016	0.00322	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—stomach cancer	0.00157	0.00317	CcSEcCtD
Phentolamine—Vomiting—Irinotecan—stomach cancer	0.00157	0.00317	CcSEcCtD
Phentolamine—Dizziness—Fluorouracil—stomach cancer	0.00157	0.00315	CcSEcCtD
Phentolamine—Mediastinal disorder—Methotrexate—stomach cancer	0.00156	0.00315	CcSEcCtD
Phentolamine—Headache—Irinotecan—stomach cancer	0.00155	0.00312	CcSEcCtD
Phentolamine—ADRA1D—endocrine gland—stomach cancer	0.00155	0.0481	CbGeAlD
Phentolamine—Hypotension—Capecitabine—stomach cancer	0.00155	0.00311	CcSEcCtD
Phentolamine—ADRA1A—hematopoietic system—stomach cancer	0.00155	0.0481	CbGeAlD
Phentolamine—Paraesthesia—Docetaxel—stomach cancer	0.00154	0.00309	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—stomach cancer	0.00153	0.00308	CcSEcCtD
Phentolamine—SIGMAR1—pancreas—stomach cancer	0.00153	0.0475	CbGeAlD
Phentolamine—Cardiac disorder—Epirubicin—stomach cancer	0.00151	0.00303	CcSEcCtD
Phentolamine—Flushing—Epirubicin—stomach cancer	0.00151	0.00303	CcSEcCtD
Phentolamine—Vomiting—Fluorouracil—stomach cancer	0.00151	0.00303	CcSEcCtD
Phentolamine—Paraesthesia—Capecitabine—stomach cancer	0.00149	0.00299	CcSEcCtD
Phentolamine—Headache—Fluorouracil—stomach cancer	0.00148	0.00299	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00148	0.00297	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—stomach cancer	0.00147	0.00297	CcSEcCtD
Phentolamine—Nausea—Irinotecan—stomach cancer	0.00147	0.00296	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—stomach cancer	0.00146	0.00295	CcSEcCtD
Phentolamine—Pain—Docetaxel—stomach cancer	0.00146	0.00294	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—stomach cancer	0.00145	0.00292	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00143	0.00288	CcSEcCtD
Phentolamine—Pain—Capecitabine—stomach cancer	0.00142	0.00285	CcSEcCtD
Phentolamine—ADRA1A—epithelium—stomach cancer	0.00141	0.0439	CbGeAlD
Phentolamine—Nausea—Fluorouracil—stomach cancer	0.00141	0.00283	CcSEcCtD
Phentolamine—Gastrointestinal pain—Docetaxel—stomach cancer	0.0014	0.00282	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—stomach cancer	0.00139	0.00281	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—stomach cancer	0.00139	0.00281	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—stomach cancer	0.00136	0.00274	CcSEcCtD
Phentolamine—Gastrointestinal pain—Capecitabine—stomach cancer	0.00135	0.00273	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—stomach cancer	0.00135	0.00273	CcSEcCtD
Phentolamine—Abdominal pain—Docetaxel—stomach cancer	0.00135	0.00272	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—stomach cancer	0.00134	0.0027	CcSEcCtD
Phentolamine—Abdominal pain—Capecitabine—stomach cancer	0.00131	0.00263	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—stomach cancer	0.00129	0.00259	CcSEcCtD
Phentolamine—NISCH—lymph node—stomach cancer	0.00128	0.0398	CbGeAlD
Phentolamine—Asthenia—Docetaxel—stomach cancer	0.00123	0.00247	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—stomach cancer	0.00122	0.00246	CcSEcCtD
Phentolamine—Pruritus—Docetaxel—stomach cancer	0.00121	0.00244	CcSEcCtD
Phentolamine—Nervous system disorder—Methotrexate—stomach cancer	0.00121	0.00243	CcSEcCtD
Phentolamine—SIGMAR1—bone marrow—stomach cancer	0.0012	0.0374	CbGeAlD
Phentolamine—Chest pain—Epirubicin—stomach cancer	0.0012	0.00242	CcSEcCtD
Phentolamine—ADRA2C—pancreas—stomach cancer	0.0012	0.0373	CbGeAlD
Phentolamine—Asthenia—Capecitabine—stomach cancer	0.00119	0.00239	CcSEcCtD
Phentolamine—ADRA2A—hematopoietic system—stomach cancer	0.00118	0.0366	CbGeAlD
Phentolamine—Pruritus—Capecitabine—stomach cancer	0.00117	0.00236	CcSEcCtD
Phentolamine—Diarrhoea—Docetaxel—stomach cancer	0.00117	0.00236	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—stomach cancer	0.00115	0.00232	CcSEcCtD
Phentolamine—Diarrhoea—Capecitabine—stomach cancer	0.00113	0.00228	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—stomach cancer	0.00113	0.00228	CcSEcCtD
Phentolamine—Dizziness—Docetaxel—stomach cancer	0.00113	0.00228	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—stomach cancer	0.00113	0.00227	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—stomach cancer	0.00113	0.00227	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—stomach cancer	0.00111	0.00224	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—stomach cancer	0.00111	0.00223	CcSEcCtD
Phentolamine—Dizziness—Capecitabine—stomach cancer	0.00109	0.0022	CcSEcCtD
Phentolamine—ADRA1A—lymphoid tissue—stomach cancer	0.00109	0.0338	CbGeAlD
Phentolamine—Vomiting—Docetaxel—stomach cancer	0.00109	0.00219	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—stomach cancer	0.00108	0.00217	CcSEcCtD
Phentolamine—Headache—Docetaxel—stomach cancer	0.00107	0.00216	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00106	0.00214	CcSEcCtD
Phentolamine—Pain—Methotrexate—stomach cancer	0.00105	0.00212	CcSEcCtD
Phentolamine—Vomiting—Capecitabine—stomach cancer	0.00105	0.00212	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—stomach cancer	0.00105	0.00211	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—stomach cancer	0.00104	0.0021	CcSEcCtD
Phentolamine—Headache—Capecitabine—stomach cancer	0.00104	0.00209	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—stomach cancer	0.00104	0.00209	CcSEcCtD
Phentolamine—Nausea—Docetaxel—stomach cancer	0.00102	0.00204	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—stomach cancer	0.00101	0.00203	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—stomach cancer	0.000997	0.00201	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000995	0.002	CcSEcCtD
Phentolamine—Pain—Epirubicin—stomach cancer	0.000986	0.00199	CcSEcCtD
Phentolamine—Nausea—Capecitabine—stomach cancer	0.000983	0.00198	CcSEcCtD
Phentolamine—Abdominal pain—Methotrexate—stomach cancer	0.000974	0.00196	CcSEcCtD
Phentolamine—SIGMAR1—liver—stomach cancer	0.000972	0.0302	CbGeAlD
Phentolamine—Paraesthesia—Doxorubicin—stomach cancer	0.000958	0.00193	CcSEcCtD
Phentolamine—ADRA2A—pancreas—stomach cancer	0.000957	0.0298	CbGeAlD
Phentolamine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000943	0.0019	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000921	0.00185	CcSEcCtD
Phentolamine—Pain—Doxorubicin—stomach cancer	0.000912	0.00184	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—stomach cancer	0.000911	0.00184	CcSEcCtD
Phentolamine—ADRA1A—endocrine gland—stomach cancer	0.000889	0.0276	CbGeAlD
Phentolamine—Asthenia—Methotrexate—stomach cancer	0.000884	0.00178	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000872	0.00176	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—stomach cancer	0.000872	0.00176	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—stomach cancer	0.000843	0.0017	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—stomach cancer	0.000843	0.0017	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—stomach cancer	0.000827	0.00167	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—stomach cancer	0.000816	0.00164	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—stomach cancer	0.000815	0.00164	CcSEcCtD
Phentolamine—ADRA1A—liver—stomach cancer	0.000801	0.0249	CbGeAlD
Phentolamine—Diarrhoea—Epirubicin—stomach cancer	0.000789	0.00159	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—stomach cancer	0.000783	0.00158	CcSEcCtD
Phentolamine—Headache—Methotrexate—stomach cancer	0.000772	0.00155	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—stomach cancer	0.000765	0.00154	CcSEcCtD
Phentolamine—ADRA2C—liver—stomach cancer	0.000763	0.0237	CbGeAlD
Phentolamine—Dizziness—Epirubicin—stomach cancer	0.000762	0.00154	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—stomach cancer	0.000755	0.00152	CcSEcCtD
Phentolamine—SIGMAR1—lymph node—stomach cancer	0.000745	0.0232	CbGeAlD
Phentolamine—Vomiting—Epirubicin—stomach cancer	0.000733	0.00148	CcSEcCtD
Phentolamine—Nausea—Methotrexate—stomach cancer	0.000732	0.00147	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—stomach cancer	0.00073	0.00147	CcSEcCtD
Phentolamine—Headache—Epirubicin—stomach cancer	0.000722	0.00145	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—stomach cancer	0.000706	0.00142	CcSEcCtD
Phentolamine—Nausea—Epirubicin—stomach cancer	0.000685	0.00138	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—stomach cancer	0.000678	0.00137	CcSEcCtD
Phentolamine—ADRA2A—endocrine gland—stomach cancer	0.000676	0.021	CbGeAlD
Phentolamine—Headache—Doxorubicin—stomach cancer	0.000668	0.00135	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—stomach cancer	0.000634	0.00128	CcSEcCtD
Phentolamine—ADRA2C—lymph node—stomach cancer	0.000585	0.0182	CbGeAlD
Phentolamine—ADRA2A—lymph node—stomach cancer	0.000467	0.0145	CbGeAlD
Phentolamine—ADRA1D—Signaling Pathways—IL6ST—stomach cancer	5.87e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ERCC2—stomach cancer	5.85e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL8—stomach cancer	5.83e-05	0.000131	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—KRAS—stomach cancer	5.79e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGFR2—stomach cancer	5.79e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	5.77e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	5.77e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IRS2—stomach cancer	5.76e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	5.71e-05	0.000129	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—APC—stomach cancer	5.64e-05	0.000127	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CAV1—stomach cancer	5.59e-05	0.000126	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APOA1—stomach cancer	5.58e-05	0.000126	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MTHFR—stomach cancer	5.5e-05	0.000124	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PPARG—stomach cancer	5.49e-05	0.000124	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	5.48e-05	0.000124	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FYN—stomach cancer	5.48e-05	0.000123	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—MAPK3—stomach cancer	5.4e-05	0.000122	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IRS2—stomach cancer	5.38e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	5.36e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	5.32e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	5.32e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	5.3e-05	0.000119	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IRS2—stomach cancer	5.3e-05	0.000119	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	5.3e-05	0.000119	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6R—stomach cancer	5.24e-05	0.000118	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CAV1—stomach cancer	5.22e-05	0.000118	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOA1—stomach cancer	5.21e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	5.18e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—stomach cancer	5.15e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	5.14e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—MAPK1—stomach cancer	5.14e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CAV1—stomach cancer	5.14e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EGFR—stomach cancer	5.14e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOA1—stomach cancer	5.13e-05	0.000115	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APC—stomach cancer	5.09e-05	0.000115	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FYN—stomach cancer	5.09e-05	0.000115	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CAV1—stomach cancer	5.07e-05	0.000114	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOA1—stomach cancer	5.06e-05	0.000114	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PRKCB—stomach cancer	4.97e-05	0.000112	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6ST—stomach cancer	4.95e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—stomach cancer	4.94e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—HRAS—stomach cancer	4.92e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—PIK3CA—stomach cancer	4.91e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SERPINE1—stomach cancer	4.9e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	4.89e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	4.88e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	4.87e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—KRAS—stomach cancer	4.85e-05	0.000109	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	4.81e-05	0.000108	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	4.78e-05	0.000108	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APC—stomach cancer	4.76e-05	0.000107	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RHOA—stomach cancer	4.73e-05	0.000107	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6R—stomach cancer	4.73e-05	0.000106	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—stomach cancer	4.72e-05	0.000106	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IRS2—stomach cancer	4.71e-05	0.000106	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—stomach cancer	4.68e-05	0.000105	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APC—stomach cancer	4.68e-05	0.000105	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	4.64e-05	0.000104	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	4.64e-05	0.000104	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CAV1—stomach cancer	4.56e-05	0.000103	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—MAPK3—stomach cancer	4.55e-05	0.000103	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOA1—stomach cancer	4.55e-05	0.000103	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	4.48e-05	0.000101	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	4.46e-05	0.0001	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARG—stomach cancer	4.46e-05	0.0001	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	4.43e-05	9.99e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	4.43e-05	9.97e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6R—stomach cancer	4.42e-05	9.95e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	4.38e-05	9.87e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	4.38e-05	9.86e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	4.37e-05	9.85e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6R—stomach cancer	4.35e-05	9.79e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	4.34e-05	9.79e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	4.33e-05	9.76e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	4.33e-05	9.76e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	4.33e-05	9.75e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—stomach cancer	4.32e-05	9.73e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	4.27e-05	9.62e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	4.26e-05	9.61e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	4.26e-05	9.6e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	4.24e-05	9.55e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	4.23e-05	9.53e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	4.23e-05	9.52e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APC—stomach cancer	4.16e-05	9.36e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	4.15e-05	9.35e-05	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	4.14e-05	9.33e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	4.13e-05	9.31e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	4.12e-05	9.29e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	4.09e-05	9.22e-05	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	4.07e-05	9.18e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	4.07e-05	9.17e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	4.05e-05	9.13e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	4.04e-05	9.09e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	4.03e-05	9.07e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	4.03e-05	9.07e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	4.02e-05	9.06e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—stomach cancer	4.01e-05	9.03e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RHOA—stomach cancer	3.99e-05	8.98e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	3.98e-05	8.97e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	3.95e-05	8.9e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—stomach cancer	3.95e-05	8.89e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—stomach cancer	3.95e-05	8.89e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RHOA—stomach cancer	3.93e-05	8.84e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—stomach cancer	3.88e-05	8.75e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCND1—stomach cancer	3.87e-05	8.71e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APC—stomach cancer	3.86e-05	8.7e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—JUN—stomach cancer	3.86e-05	8.7e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6R—stomach cancer	3.86e-05	8.7e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—stomach cancer	3.83e-05	8.64e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	3.79e-05	8.53e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	3.79e-05	8.53e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	3.76e-05	8.47e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—stomach cancer	3.76e-05	8.46e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	3.75e-05	8.44e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	3.74e-05	8.43e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	3.72e-05	8.39e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	3.7e-05	8.34e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	3.7e-05	8.33e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	3.69e-05	8.32e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	3.66e-05	8.25e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	3.65e-05	8.23e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	3.63e-05	8.19e-05	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	3.62e-05	8.15e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	3.61e-05	8.14e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	3.59e-05	8.08e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	3.58e-05	8.06e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	3.56e-05	8.03e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	3.52e-05	7.93e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	3.52e-05	7.93e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—stomach cancer	3.51e-05	7.9e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	3.5e-05	7.89e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	3.49e-05	7.87e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	3.49e-05	7.85e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—JUN—stomach cancer	3.48e-05	7.85e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	3.48e-05	7.84e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	3.45e-05	7.77e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	3.45e-05	7.76e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	3.42e-05	7.71e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	3.42e-05	7.7e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	3.39e-05	7.64e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	3.38e-05	7.61e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	3.37e-05	7.6e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	3.37e-05	7.58e-05	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	3.36e-05	7.58e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	3.36e-05	7.57e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—STAT3—stomach cancer	3.34e-05	7.52e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	3.33e-05	7.5e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	3.32e-05	7.49e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	3.3e-05	7.43e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	3.29e-05	7.4e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	3.28e-05	7.38e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	3.26e-05	7.35e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—JUN—stomach cancer	3.26e-05	7.33e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	3.24e-05	7.3e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	3.23e-05	7.27e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	3.21e-05	7.23e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	3.21e-05	7.22e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—JUN—stomach cancer	3.2e-05	7.22e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	3.19e-05	7.19e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	3.17e-05	7.13e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	3.16e-05	7.11e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	3.12e-05	7.02e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	3.11e-05	7e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MYC—stomach cancer	3.1e-05	6.99e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	3.08e-05	6.94e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	3.06e-05	6.9e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	3.05e-05	6.88e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	3.04e-05	6.86e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	3.04e-05	6.85e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	3.04e-05	6.84e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	3.03e-05	6.84e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	3.03e-05	6.83e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	3.01e-05	6.79e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	3e-05	6.76e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	2.99e-05	6.73e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.91e-05	6.56e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	2.88e-05	6.49e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	2.87e-05	6.46e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.85e-05	6.42e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.85e-05	6.41e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.84e-05	6.41e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	2.84e-05	6.41e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.83e-05	6.37e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	2.82e-05	6.34e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MYC—stomach cancer	2.8e-05	6.31e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	2.8e-05	6.3e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.78e-05	6.26e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	2.77e-05	6.24e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.77e-05	6.24e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.76e-05	6.21e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	2.74e-05	6.17e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	2.74e-05	6.17e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.7e-05	6.09e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.69e-05	6.07e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	2.69e-05	6.06e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3CA—stomach cancer	2.66e-05	5.98e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.65e-05	5.97e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.65e-05	5.96e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.64e-05	5.96e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	2.63e-05	5.93e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MYC—stomach cancer	2.62e-05	5.89e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	2.59e-05	5.83e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.58e-05	5.8e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.57e-05	5.79e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.56e-05	5.77e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	2.56e-05	5.77e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	2.56e-05	5.77e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—stomach cancer	2.55e-05	5.74e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.52e-05	5.68e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.52e-05	5.67e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.5e-05	5.64e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.49e-05	5.6e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.46e-05	5.55e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.44e-05	5.49e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	2.42e-05	5.45e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.38e-05	5.36e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	2.38e-05	5.36e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.35e-05	5.3e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—stomach cancer	2.33e-05	5.25e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.31e-05	5.2e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—stomach cancer	2.3e-05	5.18e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.29e-05	5.15e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.29e-05	5.15e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.24e-05	5.04e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.24e-05	5.04e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	2.22e-05	5e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	2.2e-05	4.96e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	2.19e-05	4.92e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.19e-05	4.92e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.16e-05	4.86e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—stomach cancer	2.15e-05	4.84e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.13e-05	4.79e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—stomach cancer	2.11e-05	4.76e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.11e-05	4.76e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—stomach cancer	2.11e-05	4.74e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	2.08e-05	4.68e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	2.08e-05	4.68e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	2.05e-05	4.63e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	2.02e-05	4.56e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.97e-05	4.43e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.96e-05	4.42e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.94e-05	4.37e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.94e-05	4.36e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.88e-05	4.23e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.8e-05	4.06e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.8e-05	4.05e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.75e-05	3.93e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.72e-05	3.87e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.67e-05	3.76e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.6e-05	3.6e-05	CbGpPWpGaD
